| Guertone Sutton, APRN | |
|
231 W Hancock St, Milledgeville, GA 31061-3371 | |
| (800) 342-0471 | |
| Not Available |
| Full Name | Guertone Sutton |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 231 W Hancock St, Milledgeville, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376138909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 235616 (Georgia) | Secondary |
| 207Q00000X | Family Medicine | 235616 (Georgia) | Primary |
| Entity Name | Southside Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235123993 PECOS PAC ID: 6901700723 Enrollment ID: O20031212000357 |
News Archive
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
In a trial that included about 35,000 men, those who were randomized to receive daily supplementation with vitamin E had a significantly increased risk of prostate cancer, according to a study in the October 12 issue of JAMA.
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.
The Centers for Disease Control and Prevention awarded LSU Health New Orleans School of Public Health's Louisiana Tumor Registry a $1.3 million grant over five years to more rapidly find and report cases of cancer in children and young adults. One of only eight state registries to successfully compete for this funding, the award will support efforts to increase the availability of this data for surveillance and research activities at the local, state and national level.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Guertone Sutton, APRN 231 W Hancock St, Milledgeville, GA 31061-3371 Ph: (800) 342-0471 | Guertone Sutton, APRN 231 W Hancock St, Milledgeville, GA 31061-3371 Ph: (800) 342-0471 |
News Archive
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
In a trial that included about 35,000 men, those who were randomized to receive daily supplementation with vitamin E had a significantly increased risk of prostate cancer, according to a study in the October 12 issue of JAMA.
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.
The Centers for Disease Control and Prevention awarded LSU Health New Orleans School of Public Health's Louisiana Tumor Registry a $1.3 million grant over five years to more rapidly find and report cases of cancer in children and young adults. One of only eight state registries to successfully compete for this funding, the award will support efforts to increase the availability of this data for surveillance and research activities at the local, state and national level.
› Verified 1 days ago